ASX - Delayed Quote AUD

Patrys Limited (PAB.AX)

Compare
0.0030
0.0000
(0.00%)
At close: 4:10:45 PM GMT+11

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
NameTitlePayExercisedYear Born
Dr. James A. Campbell B.Sc., MBA, Ph.D. MD, CEO & Executive Director 443.68k -- --
Dr. Rebecca Tunstall Vice President of Corporate Development -- -- --
Mr. Stefan Ross Company Secretary 12.67k -- --

Patrys Limited

96-100 Albert Road
Level 4
Melbourne, VIC 3205
Australia
61 3 9670 3273 https://www.patrys.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. The company dvelops Deoxymab 3E10 also called PAT-DX1 for treating primary and secondary brain cancers, and metastases that are associated with NETosis, or in combination with DNA damaging agents such as radiation and many chemotherapy drugs. In addition, it develops PAT-DX3, a full-sized antibody that has DNA-targeting properties of PAT-DX1, but different pharmaceutic properties, such as tissue distribution, pharmacokinetic profile, etc. Further, it is involved in DNA targeting, blood-brain barrier, Inhibit NETosis human therapeutic applications. Patrys Limited was incorporated in 2006 and is based in Melbourne, Australia.

Corporate Governance

Patrys Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 21, 2025 at 10:59 AM UTC - February 25, 2025 at 12:00 PM UTC

Patrys Limited Earnings Date

Recent Events

Related Tickers

VBS.AX Vectus Biosystems Limited
0.0790
0.00%
 
RNV.AX RENERVE FPO [RNV]
0.1400
-3.45%
 
TRP.AX Tissue Repair Ltd
0.3050
+7.02%
 
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0370
+2.78%
 
NYR.AX Nyrada Inc.
0.0740
-2.63%
 
ZLD.AX Zelira Therapeutics Limited
0.5500
+1.85%
 
PIQ.AX Proteomics International Laboratories Ltd
0.6450
-2.27%
 
PTX.AX Prescient Therapeutics Limited
0.0550
+1.85%
 
NOX.AX Noxopharm Limited
0.0900
-5.26%
 
SPL.AX Starpharma Holdings Limited
0.1050
0.00%